Director, Market Access - DACH

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Director, Market Access is responsible for defining and executing the market access, pricing, and reimbursement strategy for Corcept’s oncology portfolio in DACH. This role is critical to ensuring timely, sustainable, and compliant patient access through successful navigation of DACH complex access environment, including AMNOG, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Bundesausschuss (G ‑ BA), Statutory Health Insurance (SHI) negotiations, and regional access dynamics. The Director will report to DACH GM and serve as the market access lead for DACH, partnering closely with U.S. Headquarters Market Access, Health Economics and Outcomes Research (HEOR), Medical, Commercial and Legal and Compliance to drive optimal launch readiness, reimbursement outcomes, and long ‑ term access success. Responsibilities: Market Access Strategy & Leadership Develop and lead the DACH German market access strategy for Corcept’s oncology assets across the product lifecycle, from early pipeline through launch and post ‑ launch optimization Serve as the primary market access subject matter expert for DACH, advising senior leadership on access risks, opportunities, and strategic trade ‑ offs Ensure alignment between U.S. access strategy and local execution, providing clear input into German pricing, value, and evidence planning Collaborate with DACH commercial teams including marketing, sales, and medical Pricing, Reimbursement & AMNOG Execution Lead DACH ‑ specific pricing and reimbursement strategy, including launch price positioning and lifecycle price management Own and drive the AMNOG process, including: Strategic input into dossier development Engagement planning for IQWiG and G ‑ BA assessments Preparation for SHI price negotiations and arbitration scenarios Partner with U.S. teams to translate clinical and economic value into compelling, compliant value propositions for German payers Coordination with Medical, HEOR/RWE, Clinical development, and Regulatory on evidence strategy that reflects both national and regional payer expectations Stakeholder & Payer Engagement Lead strategic engagement planning with national and regional payers, sickness funds, and key decision ‑ making bodies Provide guidance and support for compliant payer communication strategies, in collaboration with HEOR/RWE, Legal and Compliance and Medical colleagues Monitor and assess evolving policy, regulatory, and reimbursement landscapes in Germany and proactively adapt access strategy Cross ‑ Functional Leadership Act as a core member of the Germany Leadership Team, partnering with U.S. Market Access. Commercial, Medical, Regulatory, and other relevant functions Ensure market access considerations are embedded early in launch planning, forecasting, and business planning Contribute to regional and European access forums, sharing insights and best practices Uphold Corcept’s ethics and patient ‑ first principles by embedding collaboration, evidence ‑ based decision ‑ making, and accountable leadership into all aspects of strategy and execution Preferred Skills, Qualifications and Technical Proficiencies: Fluency in German and English required Extensive experience in pharmaceutical market access in Germany, with deep expertise in AMNOG, G ‑ BA, IQ